UnitedHealthcare announced Tuesday that it will eliminate prior authorization requirements for nearly a third of the medical services that currently demand insurer sign-off before a doctor can proceed, a move that strips away one of the most widely despised layers of bureaucracy in American health care. The changes will roll out by the end of 2026, CBS News reported.
CEO Tim Noel framed the decision as a concession to patients and physicians alike, acknowledging what millions of Americans already know: the approval process too often stands between a sick person and the treatment a doctor has already recommended.
The policy shift lands at a moment when the health insurance industry faces extraordinary public scrutiny, and not just over paperwork. The December 2024 shooting death of former UnitedHealth CEO Brian Thompson turned a harsh national spotlight on the ways insurers manage, delay, and deny care. Luigi Mangione, the suspect in that killing, is awaiting trial in both federal and state court.
UnitedHealthcare said the eliminated requirements will span several categories of care: select outpatient surgeries, some diagnostic tests such as echocardiograms, certain outpatient therapies, and some chiropractic services. The company pledged to post the full list of affected services at UHCProvider.com before the changes take effect.
The insurer was quick to note that prior authorization currently applies to only 2% of the medical services covered under its policies. Of those, the company said, roughly 92% are approved within 24 hours.
Those numbers sound reassuring on paper. But they obscure the real-world burden. The American Medical Association found that physicians' offices spend an average of 12 hours per week seeking insurer approval for medical treatments. Twelve hours, not on patient care, not on diagnosis, not on follow-up, but on phone trees, fax machines, and insurer portals, trying to get permission to do what the doctor already decided was necessary.
For a small practice, that is a full-time employee's worth of labor every single week, consumed entirely by red tape.
UnitedHealthcare is not acting in a vacuum. Last year, a group of insurers represented by the trade association Health Insurance Plans, known as AHIP, said some of its biggest members would take steps to streamline prior authorization. That group included Blue Cross Blue Shield of California, Humana, and Kaiser Permanente.
The broader push suggests the industry recognizes that public patience with the prior authorization process has worn thin. For years, doctors and patients have complained that the system serves the insurer's bottom line far more than it protects anyone's health. A physician orders a test. The insurer demands justification. Days pass. The patient waits. Sometimes the authorization comes through. Sometimes it doesn't, and the doctor appeals. Meanwhile, the condition that prompted the order in the first place goes unaddressed.
The shooting of Brian Thompson in December 2024 brought that frustration into the open in the most disturbing way imaginable. The broader cultural fallout from the case exposed how deep public anger toward the insurance industry runs, anger that, in isolated and extreme cases, has allegedly inspired dangerous fixations.
In his statement, Noel tried to thread a needle, defending the concept of prior authorization while conceding it had been applied too broadly.
"Prior authorization is an essential safeguard but should only be used when it truly protects patients and improves care."
He added:
"Eliminating these requirements is one more way we are working to make it easier for patients to get the care they need when they need it and ensure doctors can spend more time with their patients."
The language is corporate and careful. But the underlying admission is significant. UnitedHealthcare, the largest private health insurer in the country, is conceding that a meaningful share of its own prior authorization requirements did not "truly protect patients" or "improve care." If they had, the company would not be eliminating them.
That raises a straightforward question: how many treatments were delayed or denied under requirements the company now considers unnecessary? And for how long did patients bear the consequences?
The announcement leaves several important details unresolved. UnitedHealthcare has not specified which plans, markets, or patient populations will see the changes first. The company said only that it will implement the policy by the end of 2026, a timeline that could mean next month or eighteen months from now.
The full list of affected services has not yet been published. The examples given, outpatient surgeries, echocardiograms, outpatient therapies, chiropractic care, are broad categories, not a line-item accounting. Patients and providers will have to wait for the detailed list on UHCProvider.com before they know whether a specific procedure they need falls under the new policy.
And 30% of previously authorized services, while a real reduction, still leaves 70% of those services behind the same gate. The 2% figure the company cites, prior authorization applies to only 2% of covered services, may be technically accurate, but it flattens the reality. That 2% includes some of the most consequential, time-sensitive, and expensive treatments a patient can face. A prior authorization delay on a routine blood draw is an annoyance. A delay on a cardiac procedure or a cancer screening is something else entirely.
The broader climate of public anger toward large institutions has made the insurance industry's internal practices a subject of intense national attention in ways that boardrooms did not anticipate even two years ago.
For conservative readers who value free markets and personal responsibility, the prior authorization debate cuts in a specific direction. The system was designed, in theory, to prevent waste and fraud, goals any fiscally serious person supports. But when the mechanism becomes so burdensome that it consumes 12 hours of physician staff time per week, delays medically necessary care, and effectively transfers decision-making from the doctor's office to an insurance company's review desk, it has become something else: a cost-shifting tool that protects the insurer at the patient's expense.
Market accountability should mean that when a company's practices generate this much friction, and this much public backlash, the company adjusts. UnitedHealthcare's announcement is, at minimum, an acknowledgment that the market spoke.
Whether the changes amount to genuine reform or a public-relations maneuver dressed up in patient-friendly language will depend on execution. The company's handling of other recent controversies suggests its leadership is keenly aware of how public perception can shift fast and hard.
Other major insurers, Humana, Kaiser Permanente, Blue Cross Blue Shield of California, have made similar noises about streamlining authorization. If those pledges remain vague while UnitedHealthcare follows through with specifics, the competitive pressure alone could force the rest of the industry to act. If none of them follow through in meaningful ways, the political pressure for legislative mandates will only grow.
Patients deserve to have their doctors, not insurance company algorithms, make timely medical decisions. UnitedHealthcare's move is a step in the right direction, but it is also a reminder of how far the system drifted before anyone at the top decided to act.
When the nation's largest insurer admits that nearly a third of its own approval requirements weren't doing what they were supposed to do, the right response isn't applause. It's a simple question: what took so long?
